Alzheimer's drug cited as Medicare premium jumps by $21.60

40 articles, oldest first.

1. News Advance

   Alzheimer's drug cited as Medicare premium jumps by $21.60 ↗ (opens News Advance)

   Published Nov 12, 2021

   Same headline from 35 more outlets

   News Advance's feed description

   WASHINGTON (AP) — Medicare's “Part B” outpatient premium will jump by $21.60 a month in 2022, one of the largest increases ever. Officials said Friday a new Alzheimer's drug is

2. CBS News

   Medicare's "Part B" premium jumping by $21.60 a month next year, one of largest increases ever ↗ (opens CBS News)

   Published Nov 12, 2021

   CBS News's feed description

   Officials say a new Alzheimer's drug is responsible for about half of that.

3. Portland Press Herald

   Alzheimer’s drug cited as Medicare premium jumps by $21.60 monthly ↗ (opens Portland Press Herald)

   Published Nov 12, 2021

   Portland Press Herald's feed description

   The hike means that health care will gobble up a big chunk of the Social Security cost-of-living boost.

4. The Hill

   Medicare premiums to jump in part due to pricey Alzheimer's drug ↗ (opens The Hill)

   Published Nov 12, 2021

   The Hill's feed description

   Seniors on Medicare will have to pay more than $20 more per month extra in premiums next year, a large increase that officials in part attributed to possible coverage of a pricey and controversial new Alzheimer's dr

5. Sioux City Journal

   Medicare Part B outpatient monthly premium jumps by $21.60 next year; new Alzheimer's drug cited in one of largest hikes ↗ (opens Sioux City Journal)

   Published Nov 12, 2021

   Sioux City Journal's feed description

   WASHINGTON (AP) — Medicare Part B outpatient monthly premium jumps by $21.60 next year; new Alzheimer's drug cited in one of largest hikes.

Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.